FDA puts hold on HCV drug testing at Idenix


This news may be of interest to those who are waiting for HCV treatments that are less toxic than current ones and effective in achieving SVR in more patients.  This action is related to the Bristol-Myers post made previously.

Pipeline Setback at Idenix

BMS R & D setback casts shadow on other Hep C contenders

 

Unknown's avatar

About Laura

NW Vermont.
This entry was posted in Guest authors, HCV Health, Medical News and tagged , , , , , , , , . Bookmark the permalink.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.